1.43
price up icon2.88%   0.04
after-market After Hours: 1.39 -0.04 -2.80%
loading
Acrivon Therapeutics Inc stock is traded at $1.43, with a volume of 331.39K. It is up +2.88% in the last 24 hours and up +7.52% over the past month. Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
See More
Previous Close:
$1.39
Open:
$1.41
24h Volume:
331.39K
Relative Volume:
0.44
Market Cap:
$44.84M
Revenue:
-
Net Income/Loss:
$-69.00M
P/E Ratio:
-0.5144
EPS:
-2.78
Net Cash Flow:
$-55.26M
1W Performance:
+5.93%
1M Performance:
+7.52%
6M Performance:
-73.76%
1Y Performance:
-82.92%
1-Day Range:
Value
$1.34
$1.47
1-Week Range:
Value
$1.34
$1.495
52-Week Range:
Value
$1.05
$10.16

Acrivon Therapeutics Inc Stock (ACRV) Company Profile

Name
Name
Acrivon Therapeutics Inc
Name
Phone
617-207-8979
Name
Address
480 ARSENAL WAY, SUITE 100, WATERTOWN
Name
Employee
78
Name
Twitter
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
ACRV's Discussions on Twitter

Compare ACRV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACRV
Acrivon Therapeutics Inc
1.43 43.58M 0 -69.00M -55.26M -2.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades

Date Action Analyst Rating Change
May-05-25 Resumed Piper Sandler Overweight
Jan-31-25 Initiated KeyBanc Capital Markets Overweight
Sep-16-24 Upgrade Ladenburg Thalmann Neutral → Buy
Apr-29-24 Downgrade Ladenburg Thalmann Buy → Neutral
Mar-01-24 Initiated JMP Securities Mkt Outperform
Dec-15-23 Resumed Jefferies Buy
Oct-05-23 Initiated Maxim Group Buy
Jun-02-23 Initiated Oppenheimer Outperform
May-08-23 Initiated BMO Capital Markets Outperform
Apr-27-23 Initiated Ladenburg Thalmann Buy
Apr-20-23 Initiated H.C. Wainwright Buy
Dec-12-22 Initiated Cowen Outperform
Dec-12-22 Initiated Jefferies Buy
Dec-12-22 Initiated Piper Sandler Overweight
View All

Acrivon Therapeutics Inc Stock (ACRV) Latest News

pulisher
Jul 24, 2025

How high can Acrivon Therapeutics Inc. stock price go in 2025Free Group Entry - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

Acrivon Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Acrivon Therapeutics Inc. stockRapid wealth creation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Acrivon Therapeutics Inc. a good long term investmentHigh-octane investment gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Acrivon Therapeutics Inc. stock priceConsistently superior profits - PrintWeekIndia

Jul 22, 2025
pulisher
Jul 18, 2025

Is Acrivon Therapeutics Inc. stock a good hedge against inflationSolid Return Trade Selections - beatles.ru

Jul 18, 2025
pulisher
Jul 17, 2025

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Analysts Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.71 - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

What makes Acrivon Therapeutics Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

How Acrivon Therapeutics Inc. stock performs during market volatilityAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - GlobeNewswire Inc.

Jul 15, 2025
pulisher
Jul 15, 2025

Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionExpert Backed Predictions - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

(ACRV) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 11, 2025

Acrivon Therapeutics (NASDAQ:ACRV) Trading 0.7% Higher – Still a Buy? - Defense World

Jul 11, 2025
pulisher
Jun 22, 2025

Acrivon Therapeutics, Inc.(NasdaqGM: ACRV) dropped from S&P Global BMI Index - MarketScreener

Jun 22, 2025
pulisher
Jun 21, 2025

Learn to Evaluate (ACRV) using the Charts - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 13, 2025

Acrivon Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Analysts Offer Predictions for ACRV FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Long Term Trading Analysis for (ACRV) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Sells 12,377 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

Jun 07, 2025
pulisher
May 31, 2025

Northern Trust Corp Has $706,000 Stock Position in Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

May 31, 2025

Acrivon Therapeutics Inc Stock (ACRV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):